Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 2, 2003, Pages 489-493

  Reinert, Ralf René ^a   Lütticken, Rudolf ^a   Bryskier, André ^b   Al Lahham, Adnan ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; GERMANY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; PHARYNGITIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; GENOTYPE; GERMANY; HUMANS; INFANT; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0037308485     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.2.489-493.2003     Document Type: Article

References (28)

1. Adam, D., H. Scholz, and M. Helmerking. 2000. Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae. J. Infect. Dis. 182: 509-516.
2. Baquero, F. 1995. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb. Drug Resist. 1:115-120.
3. Bemer-Melchior, P., M. E. Juvin, S. Tassin, A. Bryskier, G. C. Schito, and H. B. Drugeon. 2000. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob. Agents Chemother. 44:2999-3002.
4. Brandt, C. M., M. Honscha, N. D. Truong, R. Holland, B. Hovener, A. Bryskier, R. Lütticken, and R. R. Reinert. 2001. Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany. Microb. Drug Resist. 7:165-170.
5. Canu, A., B. Malbruny, M. Coquemont, T. A. Davies, P. C. Appelbaum, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125-131.
6. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev, 13:470-511.
7. Depardieu, F., and P. Courvalin. 2001. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:319-323.
8. Enright, M. C., B. G. Spratt, A. Kalia, J. H. Cross, and D. E. Bessen. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416-2427.
9. Fitoussi, F., C. Doit, P. Geslin, N. Brahimi, and E. Bingen. 2001. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob. Agents Chemother. 45:636-638.
10. Hermans, P. W. M., M. Sluijter, K. Elzenaar, A. van Veen, J. Schonkeren, F. Nooren, W. van Leeuwen, A. de Neeling, B. van Klingeren, H. Verbrugh, and R. de Groot. 1997. Penicillin-resistant Streptococcuspneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J. Infect. Dis. 175:1413-1422.
11. Hoban, D. J., A. K. Wierzbowski, K. Nichol, and, G. G. Zhanel. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides Antimicrob. Agents Chemother. 45:2147-2150.
12. Jalava, J., J. Kataja, H. Seppala, and P. Huovinen. 2001. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob. Agents Chemother. 45:789-793.
13. Johnston, N. J., J. C. De Azavedo, J. D. Kellner, and D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2425-2426.
14. Kataja, J., P. Huovinen, M. Skurnik, H. Seppala, et al. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
15. Musher, D. M. 1992. Infections caused by Streptococcuspneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 14:801-807.
16. Nagai, K., P. C. Appelbaum, T. A. Davies, L. M. Kelly, D. B. Hoellman, A. T. Andrasevic, L. Drukalska, W. Hryniewicz, M. R. Jacobs, J. Kolman, J. Miciuleviciene, M. Pana, L. Setchanova, M. K. Thege, H. Hupkova, J. Trupl, and P. Urbaskova. 2002. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries. Antimicrob. Agents Chemother. 46:371-377.
17. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (M7-A4). Approved standard M100-S8, 4th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Nielsen, S. V., and J. Henrichsen. 1996. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol. Infect. 117: 411-416.
19. Perez-Trallero, E., C. Fernandez-Mazarrasa, C. Garcia-Rey, E. Bouza, L. Aguilar, J. Garcia-de-Lomas, and F. Baquero. 2001. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45:3334-3340.
20. Podbielski, A., B. Melzer, and R. Lutticken. 1991. Application of the polymerase chain reaction to study the M protein(-like) gene family in betahemolytic streptococci. Med. Microbiol. Immunol. 180:213-227.
21. Reinert, R. R., A. Al-Lahham, M. Lemperle, C. Tenholte, C. Briefs, S. Haupts, H. H. Gerards, and R. Lütticken. 2002. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J. Antimicrob. Chemother. 49:61-68.
22. Reinert, R. R., A. Bryskier, and R. Lütticken. 1998. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. Antimicrob. Agents Chemother. 42:1509-1511.
23. Reinert, R. R., S. Simic, A. Al-Lahham, S. Reinert, M. Lemperle, and R. Lütticken. 2001. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study. J. Clin. Microbiol. 39:1187-1189.
24. Sutcliffe, J., A. Tait Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
25. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe. 1997. MefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.
26. Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
27. Trieu-Cuot, P., C. Poyart-Salmeron, C. Carlier, and P. Courvalin. 1990. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Research 18:3660.
28. von Kries, R., A. Siedler, H. J. Schmitt, and R. R. Reinert. 2000. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin. Infect. Dis. 31:482-487.